YUCAIPA, Calif., Sept. 18, 2008 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Other OTC:ITEC.PK - News), an emerging medical device manufacturer within the $4-Billion respiratory device market, announced today that it has recently signed a 3 year distribution agreement with MacNicol & Associates, Inc. in Toronto, Canada for the distribution of Oxyview(r) and OxyAlert(r) products.
The Canadian Thoracic Society’s (CTS) COPD Guidelines Dissemination and Implementation (D&I) committee has recently initiated a five year plan to promote the COPD Guidelines and its key messages. Canada continues their efforts to raise awareness within the health care community of the existence of the COPD Guidelines with the objective of improving the treatment and management of COPD in Canada. Ingen is working to introduce Oxyview(r) and OxyAlert(r) into the Canadian markets during this time when COPD is a major concern.
According to the Public Health Agency of Canada, over 3 million Canadians cope with one of five serious respiratory diseases -- asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), and cystic fibrosis. These and other respiratory diseases such as influenza, pneumonia, bronchiolitis, respiratory distress syndrome and sleep apnea affect individuals of all ages, cultures and backgrounds -- from children to parents to grandparents.
For more information please visit:
http://www.ingen-tech.com
http://www.phac-aspc.gc.ca/publicat/2007/lbrdc-vsmrc/index-eng.php#tphp
http://209.85.141.104/search?q=cache:9iplVMd_xr8J:csrt.com/user_files/COPD_Guideline_Update-CJRT-Jan_2007.pdf+canadian+respiratory+health+care+market&hl=en&ct=clnk&cd=2&gl=us
About Ingen Technologies, Inc.
Ingen is an emerging public company that introduced Oxyview(r) into the respiratory market in 2007; the world’s first in-line oxygen flow meter. The company has expanded its distribution in North America and Asia, all of which reflect a multitude of cultures, nationalities, religions, expertise and ideas. Ingen has branded the Oxyview(r) with every major professional publication, and has gained the support from national recognized affiliates. The Company continues to adopt new OEM partners and expand the hospital based Group Purchasing Organizations as a part of the expansion program for distribution. According to the 2002 CDC Report, there are approximately 32 million people living in the United States that suffer from Chronic Obstructive Pulmonary Disease, more commonly known as ``COPD’’. COPD is the major cause of hospitalizations and the fifth leading cause of death in the United States. A large portion of the COPD patients receive oxygen therapy. Ingen Technologies owns the patents and trademarks for Oxyview(r) and OxyAlert(r), and there are no other products that compete or simulate either of these two products within the medical industry.
A Member of the Better Business Bureau A Member of the Chamber of Commerce A Licensed Business in the City of Yucaipa A Registered & Licensed Manufacturer with FDA/DHS
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Contact:
Ingen Technologies, Inc. Chris Wirth, Director (909) 790-7180 Fax: (909) 795-6340 Info@ingen-tech.com 35193 Avenue “A” Yucaipa, California 92399
Source: Ingen Technologies, Inc.
